920979-03-9 Usage
Molecular structure
A compound consisting of a pyrrolopyridine core, with a carboxyl group, a fluorophenylmethyl group, and a phenyl group attached to it.
Molecular weight
337.35 g/mol the mass of one mole of the compound, based on its molecular formula.
Appearance
A pale yellow or white crystalline solid the physical form and color of the compound.
Solubility
Soluble in organic solvents like DMSO, ethanol, and methanol the solvents in which the compound can dissolve.
Biological activity
Potential therapeutic agent for the treatment of various diseases, including cancer and inflammatory disorders the possible medical applications of the compound.
Targeting specific biological pathways
The ability to interact with specific targets in the biological system, contributing to its therapeutic effects.
Ethyl ester derivative
A derivative of the 1-[(3-fluorophenyl)methyl]-5-phenyl-1H-pyrrolo[2,3-c]pyridine-2-carboxylic acid, with an ethyl ester group attached to the carboxyl group.
Class of compounds
Pyrrolopyridine compounds a group of organic compounds with a similar structure and properties.
Pharmaceutical potential
Promising candidate for further research and development in the pharmaceutical industry due to its unique structure and properties.
Check Digit Verification of cas no
The CAS Registry Mumber 920979-03-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,2,0,9,7 and 9 respectively; the second part has 2 digits, 0 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 920979-03:
(8*9)+(7*2)+(6*0)+(5*9)+(4*7)+(3*9)+(2*0)+(1*3)=189
189 % 10 = 9
So 920979-03-9 is a valid CAS Registry Number.
920979-03-9Relevant academic research and scientific papers
N-(ARYLALKYL)-1H-PYRROLOPYRIDINE-2-CARBOXAMIDE DERIVATIVES, PREPARATION AND THERAPEUTIC USE THEREOF
-
Page/Page column 16, (2008/12/05)
The invention concerns compounds of general formula (I), wherein n, the pyrrolopyridine ring, X, Z1, Z2, Z3, Z4, Z5 and W are as defined herein. The invention also concerns a method for preparing said compounds and their therapeutic use.
